Join the club for FREE to access the whole archive and other member benefits.

Targeted nanoparticles in cancer therapy can reduce side effects

Calcium and citrate filled nanoparticles selectively kills cancer cells in mice

15-Dec-2020

Key points from article :

Many chemotherapeutic agents used to treat cancers are associated with side-effects of varying severity.

A class of novel amorphous nanoparticles made up of calcium and citrate are capable of killing tumor cells in a targeted fashion.

Amorphous and porous nanoparticles are encapsulated in a lipid layer.

Ensures that these particles are readily taken up by cells without triggering countermeasures.

Experiments on cultured cells revealed that the particles are selectively lethal.

“We found that the more aggressive the tumor, the greater the killing effect,” - Hanna Engelke, researcher.

Cancer cells causes a rupture of this outer membrane.

In healthy cells, outermost layer retains its integrity.

“Highly selective toxicity of the particles made it possible to successfully treat highly aggressive pleural tumors in mice,” - Dr Engelke.

Over the course of a 2-month treatment, no signs of serious side-effects were detected.

Research by University of Munich (LMU) published in Cell press journal.

Mentioned in this article:

Click on resource name for more details.

Cell Press

Publisher of biomedical journals including Cell, Neuron and many others

Hanna Engelke

Biophysics researcher at LMU Munich

LMU Munich (Ludwig-Maximilians-Universitat Munchen)

Public research university in Munich, Germany

Topics mentioned on this page:
Cancer, Nanomedicines